We are live on ! Find out more
AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Est. Return 0.94%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+0.94%
3 Year Est. Return
+28.59%
5 Year Est. Return
+40.78%
10 Year Est. Return
AUM
$307M
AUM Growth
+$20.4M
Cap. Flow
+$11.1M
Cap. Flow %
3.61%
Top 10 Hldgs %
29.82%
Holding
1,175
New
79
Increased
283
Reduced
241
Closed
135

Sector Composition

Rank Sector Weight
1 Financials 7.41%
2 Technology 4.46%
3 Communication Services 3.37%
4 Healthcare 3.28%
5 Industrials 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRL
826
DELISTED
NEW IRELAND FUND INC
IRL
$5K ﹤0.01%
375
HZN
827
DELISTED
Horizon Global Corporation
HZN
$5K ﹤0.01%
280
-145
-34% -$2.36K
WMC
828
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$5K ﹤0.01%
45
KRA
829
DELISTED
Kraton Corporation
KRA
$5K ﹤0.01%
125
ZIXI
830
DELISTED
Zix Corporation
ZIXI
$5K ﹤0.01%
1,000
ADMS
831
DELISTED
Adamas Pharmaceuticals
ADMS
$5K ﹤0.01%
+250
New +$4.58K
GWPH
832
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5K ﹤0.01%
50
OCSI
833
DELISTED
Oaktree Strategic Income Corporation
OCSI
$5K ﹤0.01%
550
DF
834
DELISTED
Dean Foods Company
DF
$5K ﹤0.01%
424
PNTR
835
DELISTED
Pointer Telocation Ltd.
PNTR
$5K ﹤0.01%
300
IDTI
836
DELISTED
Integrated Device Technology I
IDTI
$5K ﹤0.01%
200
AFSI
837
DELISTED
AmTrust Financial Services, Inc.
AFSI
$5K ﹤0.01%
358
BCR
838
DELISTED
CR Bard Inc.
BCR
$5K ﹤0.01%
15
ALB icon
839
Albemarle
ALB
$14B
$4K ﹤0.01%
+30
New +$3.57K
APA icon
840
APA Corp
APA
$12.3B
$4K ﹤0.01%
+94
New +$4.14K
AVXL icon
841
Anavex Life Sciences
AVXL
$297M
$4K ﹤0.01%
1,000
BBDC icon
842
Barings BDC
BBDC
$882M
$4K ﹤0.01%
268
-72
-21% -$1.08K
BLE
843
DELISTED
BlackRock Municipal Income Trust II
BLE
$4K ﹤0.01%
260
CAH icon
844
Cardinal Health
CAH
$56B
$4K ﹤0.01%
56
+37
+195% +$2.62K
CPRX
845
DELISTED
Catalyst Pharmaceutical
CPRX
$4K ﹤0.01%
1,500
DD icon
846
DuPont de Nemours
DD
$19.9B
$4K ﹤0.01%
23
-576
-96% -$96.1K
DGX icon
847
Quest Diagnostics
DGX
$26B
$4K ﹤0.01%
45
-29
-39% -$3.08K
ED icon
848
Consolidated Edison
ED
$39.9B
$4K ﹤0.01%
+50
New +$4.14K
EWX icon
849
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$684M
$4K ﹤0.01%
75
-22
-23% -$1.07K
GWW icon
850
W.W. Grainger
GWW
$60.7B
$4K ﹤0.01%
21

Similar funds

Advantage Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Advantage Investment Management held 1,175 positions worth $307M, up 7.1% from $286M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Advantage Investment Management deployed $11.1M of net new capital in Q3 2017, opening 79 new positions and adding to 283 existing holdings. Its largest new stake was iShares Russell Top 200 Growth ETF: 24,219 shares worth $1.64M.

By sector, the portfolio is most concentrated in Financials at 7.4% of assets, down from 7.5% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was First Trust Value Line Dividend Fund, an estimated $10.7M trimmed.

  • Advantage Investment Management's largest Q3 2017 buy was iShares Russell Top 200 Growth ETF: 24,219 shares worth $1.64M.
  • Advantage Investment Management added most to iShares Core S&P 500 ETF in Q3 2017, an estimated $12.8M increase.
  • Advantage Investment Management's biggest Q3 2017 reduction was First Trust Value Line Dividend Fund, cutting an estimated $10.7M.
  • Advantage Investment Management fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q3 2017, selling an estimated $1.27M.
  • Advantage Investment Management's ten largest holdings make up 30% of its $307M portfolio in Q3 2017.
  • Advantage Investment Management opened 79 new positions and closed 135 in Q3 2017.
  • Advantage Investment Management's portfolio value rose 7.1% quarter-over-quarter to $307M.

Based on Advantage Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.